transcription factor foxo1 mediates cell survival during bcr inhibitor therapy in cll
Published 10 months ago • 105 plays • Length 2:01Download video MP4
Download video MP3
Similar videos
-
2:13
cll at a genomic level
-
1:12
primary analysis of transcend-cll-004: liso-cel in r/r cll
-
1:37
the importance of genomic testing in the diagnosis of cll
-
1:28
genomic testing in cll
-
1:09
early results from epcore cll-1 trial: subcutaneous epcoritamab in patients with richter’s syndrome
-
1:52
evaluating surrogacy endpoints in cll clinical trials
-
2:49
leukemic cell birth rate & the role of recently divided b cells in cll
-
1:27
pre-leukemic state and cll show similar genomic landscapes: what does this tell us?
-
2:37
next steps for genetic testing in cll
-
2:13
resistance mechanisms in cll and the importance of genomic re-testing
-
2:51
genetic markers in patients with early-stage cll treated with ibrutinib: findings from cll12
-
1:19
single-cell sequencing of circulating tumor cells to predict progression from mgus/smm
-
1:59
a strategy for curing cll, one clone at a time
-
1:07
a future study linking tumor genetics with cll dynamics
-
2:01
encapsulation: cell-free transcription & translation machinery in vesicles l protoocl preview
-
0:28
label-free live cell imaging: t-cells killing cancer cells - zoomed-in
-
1:36
using genomics to predict cll progression
-
1:27
current and future cll diagnostic tools
-
2:25
update from murano trial: venetoclax-rituximab leads to slower clonal growth rate in cll